ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 144 filers reported holding ZIOPHARM ONCOLOGY INC in Q4 2016. The put-call ratio across all filers is 1.48 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,260 | -74.2% | 24,737 | 0.0% | 0.00% | – |
| Q2 2023 | $12,616 | -19.0% | 24,737 | +0.0% | 0.00% | – |
| Q1 2023 | $15,582 | +7.8% | 24,733 | +11.0% | 0.00% | – |
| Q4 2022 | $14,460 | -67.9% | 22,277 | -15.1% | 0.00% | – |
| Q3 2022 | $45,000 | +40.6% | 26,237 | +0.2% | 0.00% | – |
| Q2 2022 | $32,000 | +88.2% | 26,187 | +1.2% | 0.00% | – |
| Q1 2022 | $17,000 | -43.3% | 25,887 | -5.4% | 0.00% | – |
| Q4 2021 | $30,000 | -40.0% | 27,358 | -1.1% | 0.00% | – |
| Q3 2021 | $50,000 | -26.5% | 27,670 | +7.0% | 0.00% | – |
| Q2 2021 | $68,000 | -37.0% | 25,858 | -31.8% | 0.00% | – |
| Q1 2021 | $108,000 | +47.9% | 37,898 | +30.5% | 0.00% | – |
| Q4 2020 | $73,000 | -3.9% | 29,040 | -3.3% | 0.00% | – |
| Q3 2020 | $76,000 | -23.2% | 30,040 | 0.0% | 0.00% | – |
| Q2 2020 | $99,000 | +13.8% | 30,040 | -15.5% | 0.00% | – |
| Q1 2020 | $87,000 | -44.2% | 35,548 | +7.6% | 0.00% | – |
| Q4 2019 | $156,000 | -56.3% | 33,048 | -60.3% | 0.00% | -100.0% |
| Q3 2019 | $357,000 | -32.0% | 83,320 | -7.5% | 0.00% | -50.0% |
| Q2 2019 | $525,000 | +81.7% | 90,120 | +20.0% | 0.00% | +100.0% |
| Q1 2019 | $289,000 | +155.8% | 75,120 | +24.8% | 0.00% | – |
| Q4 2018 | $113,000 | -50.0% | 60,196 | -14.7% | 0.00% | -100.0% |
| Q3 2018 | $226,000 | +6.1% | 70,601 | -0.0% | 0.00% | 0.0% |
| Q2 2018 | $213,000 | -22.0% | 70,621 | +1.4% | 0.00% | 0.0% |
| Q1 2018 | $273,000 | -5.5% | 69,621 | -0.3% | 0.00% | 0.0% |
| Q4 2017 | $289,000 | -21.0% | 69,829 | +17.0% | 0.00% | -50.0% |
| Q3 2017 | $366,000 | -3.4% | 59,671 | -2.0% | 0.00% | 0.0% |
| Q2 2017 | $379,000 | +3.3% | 60,863 | +5.2% | 0.00% | 0.0% |
| Q1 2017 | $367,000 | +358.8% | 57,863 | +289.3% | 0.00% | – |
| Q4 2016 | $80,000 | +29.0% | 14,863 | +35.6% | 0.00% | – |
| Q3 2016 | $62,000 | -63.3% | 10,964 | -64.5% | 0.00% | -100.0% |
| Q2 2016 | $169,000 | +111.2% | 30,864 | +185.1% | 0.00% | 0.0% |
| Q1 2016 | $80,000 | +23.1% | 10,824 | +37.9% | 0.00% | 0.0% |
| Q4 2015 | $65,000 | -12.2% | 7,848 | -3.9% | 0.00% | 0.0% |
| Q3 2015 | $74,000 | +572.7% | 8,166 | +716.6% | 0.00% | – |
| Q1 2015 | $11,000 | +1000.0% | 1,000 | +150.0% | 0.00% | – |
| Q3 2014 | $1,000 | -96.2% | 400 | -93.3% | 0.00% | – |
| Q4 2013 | $26,000 | – | 6,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 9,709,607 | $60,394,000 | 3.07% |
| MSD Partners, L.P. | 3,410,500 | $21,213,000 | 1.32% |
| MILLER VALUE PARTNERS, LLC | 4,926,456 | $30,643,000 | 1.24% |
| Michael & Susan Dell Foundation | 66,749 | $415,000 | 0.33% |
| ACUTA CAPITAL PARTNERS, LLC | 150,000 | $933,000 | 0.26% |
| Piermont Capital Management Inc. | 85,500 | $532,000 | 0.15% |
| A.R.T. Advisors, LLC | 411,547 | $2,559,000 | 0.14% |
| EQUITEC PROPRIETARY MARKETS, LLC | 96,100 | $598,000 | 0.14% |
| Vident Investment Advisory, LLC | 204,744 | $1,274,000 | 0.10% |
| EQUITEC PROPRIETARY MARKETS, LLC | 68,800 | $428,000 | 0.10% |